Antitrust & Competition Life Sciences 1H 2026 Update
Antitrust & Competition Life Sciences 1H 2026 Update
The first half of 2026 featured a slew of significant M&A activity, regulatory developments abroad, and important jury verdicts in the life sciences space. As industry participants consider their next moves, it remains imperative to keep a close eye on the FTC in particular.... By: Goodwin
Related News
US charges two over laundering $43 million from investment fraud
Unknown31 minutes ago
CVE-2026-59886 pyasn1: Uncontrolled resource consumption when converting decoded REAL values
Unknown41 minutes ago
CVE-2026-59884 pyasn1 BER/CER/DER decoder denial of service via unbounded long-form tag IDs
Unknown42 minutes ago